| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 24 | 2024 | 12039 | 1.580 |
Why?
|
| Early Detection of Cancer | 7 | 2024 | 1344 | 1.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2021 | 573 | 1.070 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2023 | 94 | 0.810 |
Why?
|
| Lung | 9 | 2024 | 3284 | 0.780 |
Why?
|
| Protein Subunits | 1 | 2021 | 278 | 0.730 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2020 | 60 | 0.690 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2020 | 125 | 0.650 |
Why?
|
| Lung Transplantation | 1 | 2023 | 380 | 0.630 |
Why?
|
| STAT3 Transcription Factor | 5 | 2020 | 1132 | 0.610 |
Why?
|
| Inositol | 1 | 2017 | 27 | 0.600 |
Why?
|
| Respiratory Mucosa | 1 | 2018 | 211 | 0.550 |
Why?
|
| Interleukin-6 | 2 | 2017 | 1032 | 0.530 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 277 | 0.520 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5582 | 0.500 |
Why?
|
| Cell Lineage | 1 | 2018 | 697 | 0.480 |
Why?
|
| Alveolar Epithelial Cells | 3 | 2020 | 50 | 0.470 |
Why?
|
| Proteomics | 3 | 2022 | 1425 | 0.460 |
Why?
|
| beta Catenin | 1 | 2018 | 687 | 0.460 |
Why?
|
| Biomarkers, Tumor | 5 | 2024 | 10726 | 0.450 |
Why?
|
| Epithelial Cells | 3 | 2018 | 1874 | 0.450 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 2811 | 0.400 |
Why?
|
| Macrophages | 1 | 2017 | 1334 | 0.380 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 3707 | 0.290 |
Why?
|
| Drosophila Proteins | 4 | 2006 | 887 | 0.280 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 42 | 0.260 |
Why?
|
| Genome, Insect | 1 | 2006 | 97 | 0.250 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 1061 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 7055 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2022 | 1404 | 0.230 |
Why?
|
| Circulating MicroRNA | 1 | 2024 | 24 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2019 | 1491 | 0.230 |
Why?
|
| Tumor Microenvironment | 6 | 2022 | 3054 | 0.220 |
Why?
|
| Thyroid Nuclear Factor 1 | 2 | 2022 | 50 | 0.220 |
Why?
|
| Immunity | 2 | 2022 | 352 | 0.210 |
Why?
|
| Humans | 31 | 2024 | 270713 | 0.210 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 4992 | 0.190 |
Why?
|
| Animals | 20 | 2022 | 61357 | 0.190 |
Why?
|
| Proteoglycans | 1 | 2022 | 278 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 291 | 0.180 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 77 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 1 | 2022 | 147 | 0.180 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 235 | 0.180 |
Why?
|
| Mice | 13 | 2022 | 35421 | 0.170 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2017 | 119 | 0.170 |
Why?
|
| Transcriptome | 2 | 2019 | 1959 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2020 | 253 | 0.160 |
Why?
|
| Organogenesis | 1 | 2019 | 99 | 0.160 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1101 | 0.160 |
Why?
|
| Evolution, Molecular | 2 | 2019 | 866 | 0.150 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 156 | 0.150 |
Why?
|
| Glaucoma | 1 | 2019 | 103 | 0.150 |
Why?
|
| Biomarkers | 4 | 2023 | 5048 | 0.150 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 881 | 0.150 |
Why?
|
| Prostate | 1 | 2023 | 1090 | 0.150 |
Why?
|
| Neoplasms | 2 | 2021 | 15949 | 0.150 |
Why?
|
| Mutation | 8 | 2022 | 15917 | 0.140 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2017 | 16 | 0.140 |
Why?
|
| Myopia | 1 | 2019 | 196 | 0.140 |
Why?
|
| Cytokines | 2 | 2023 | 2803 | 0.140 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 165 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 4105 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2020 | 5657 | 0.140 |
Why?
|
| Estrogens | 1 | 2020 | 806 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2020 | 1555 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2024 | 2882 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2020 | 1580 | 0.130 |
Why?
|
| Drosophila | 4 | 2006 | 895 | 0.130 |
Why?
|
| Interleukins | 1 | 2018 | 340 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 313 | 0.130 |
Why?
|
| Anticarcinogenic Agents | 1 | 2017 | 368 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 863 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2024 | 2376 | 0.130 |
Why?
|
| Proteome | 2 | 2017 | 570 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 1388 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 677 | 0.120 |
Why?
|
| Cell Plasticity | 1 | 2015 | 66 | 0.120 |
Why?
|
| Body Fluids | 1 | 2016 | 121 | 0.120 |
Why?
|
| Embryo, Mammalian | 1 | 2018 | 744 | 0.120 |
Why?
|
| Male | 15 | 2024 | 128479 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 2454 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 220 | 0.120 |
Why?
|
| Proteins | 1 | 2022 | 2030 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 1065 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2020 | 1031 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2023 | 6766 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2020 | 6233 | 0.110 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 203 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 1656 | 0.110 |
Why?
|
| Inflammation | 1 | 2023 | 2491 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 7317 | 0.110 |
Why?
|
| Models, Biological | 1 | 2021 | 3186 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2016 | 593 | 0.100 |
Why?
|
| Cadherins | 1 | 2016 | 659 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 4202 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2017 | 417 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2017 | 4907 | 0.090 |
Why?
|
| Retina | 2 | 2005 | 550 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2016 | 1420 | 0.090 |
Why?
|
| Bronchi | 1 | 2012 | 325 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 3427 | 0.090 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2010 | 40 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 1420 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 1002 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 3241 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1456 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2015 | 751 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 1535 | 0.080 |
Why?
|
| Female | 14 | 2024 | 148885 | 0.080 |
Why?
|
| Eye Proteins | 3 | 2005 | 279 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2018 | 5692 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2022 | 5415 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 14878 | 0.070 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 560 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2020 | 341 | 0.060 |
Why?
|
| Pregnancy | 1 | 2018 | 7916 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 894 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 31116 | 0.060 |
Why?
|
| Acrylamides | 1 | 2024 | 68 | 0.060 |
Why?
|
| Mass Screening | 2 | 2023 | 1547 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10268 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2021 | 6344 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 3435 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 4468 | 0.050 |
Why?
|
| Aged | 5 | 2024 | 73613 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 189 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 489 | 0.050 |
Why?
|
| Middle Aged | 6 | 2024 | 90533 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2024 | 206 | 0.050 |
Why?
|
| Liquid Biopsy | 1 | 2023 | 167 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1648 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2018 | 398 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 7920 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2019 | 1034 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 5759 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 5604 | 0.050 |
Why?
|
| Genome | 2 | 2005 | 689 | 0.040 |
Why?
|
| Carbonic Anhydrase IV | 1 | 2020 | 1 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2000 | 68 | 0.040 |
Why?
|
| Propanolamines | 1 | 2000 | 46 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 9048 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 2478 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2017 | 7232 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2024 | 1060 | 0.040 |
Why?
|
| Cardiac Output, Low | 1 | 2000 | 72 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2020 | 93 | 0.040 |
Why?
|
| Disease Progression | 2 | 2024 | 6881 | 0.040 |
Why?
|
| Genes, ras | 1 | 2022 | 678 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2018 | 12042 | 0.040 |
Why?
|
| Adult | 4 | 2024 | 82041 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2020 | 316 | 0.040 |
Why?
|
| Indoles | 1 | 2024 | 1029 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 1323 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 1260 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14638 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 840 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2019 | 571 | 0.040 |
Why?
|
| CD146 Antigen | 1 | 2017 | 54 | 0.040 |
Why?
|
| Neutrophils | 1 | 2022 | 855 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 316 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 7787 | 0.040 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 115 | 0.040 |
Why?
|
| Prognosis | 3 | 2024 | 22528 | 0.040 |
Why?
|
| Pemetrexed | 1 | 2017 | 100 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2019 | 4104 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 402 | 0.030 |
Why?
|
| Thiophenes | 1 | 2017 | 147 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2000 | 529 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 515 | 0.030 |
Why?
|
| Urea | 1 | 2017 | 301 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 674 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 757 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 341 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2016 | 263 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 354 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5145 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1072 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1188 | 0.030 |
Why?
|
| Algorithms | 1 | 2024 | 3906 | 0.030 |
Why?
|
| Survival Rate | 2 | 2017 | 12530 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2005 | 6639 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2016 | 606 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2419 | 0.030 |
Why?
|
| Budesonide | 1 | 2012 | 35 | 0.030 |
Why?
|
| Eye | 2 | 2004 | 284 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2012 | 127 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2396 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2024 | 3671 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 299 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 3841 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 396 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2017 | 1389 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1032 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2024 | 39959 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 906 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 1704 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2010 | 5674 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 6502 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2312 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 3568 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 3606 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2051 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 4332 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 3582 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 5056 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2012 | 610 | 0.020 |
Why?
|
| Sinusitis | 1 | 2010 | 148 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 5099 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 4532 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 7052 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6257 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 7648 | 0.020 |
Why?
|
| United States | 1 | 2024 | 15828 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 17861 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1409 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 5923 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3464 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 12978 | 0.020 |
Why?
|
| Response Elements | 1 | 2005 | 192 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 337 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 460 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 734 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 243 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5417 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 497 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 771 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 579 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 7755 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1469 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 4838 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 14033 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22243 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 1124 | 0.010 |
Why?
|
| Exocytosis | 1 | 2000 | 117 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 2000 | 83 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 228 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2000 | 240 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 1715 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 5405 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 1082 | 0.010 |
Why?
|
| Edema | 1 | 2000 | 264 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2000 | 384 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 464 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 563 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 2492 | 0.010 |
Why?
|
| Myocardium | 1 | 2000 | 1180 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 3490 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 4202 | 0.010 |
Why?
|